Heather Bresch
Chief Executive Officer at Mylan Pharmaceuticals, Inc.
Profile
Heather Bresch is the CEO of Mylan, Inc., a Pittsburgh-based pharmaceutical corporation that describes itself as the third largest generics and specialty pharmaceutical company in the world.
Career
Bresch's previous roles included serving as Mylan's president, chief operating officer, head of North American operations and chief integration officer. She has been active in attempts to prevent brand-name pharmaceuticals from delaying the release of generic drugs and appeared before a special United States Senate committee on the issue in 2006 and again in 2009. Bresch also testified before the Food and Drug Administration in September 2010 on the issue of generic drug user fees, proposing a new user fee structure that aims to generate more funding for the FDA and provide greater assurance for pharmaceutical product safety, regardless of where in the world the product or its ingredients come from. Also in 2011, Bresch was named one of Pharmaceutical Executive's "Emerging Pharma Leaders 2011."
Controversy
Bresch, the daughter of West Virginia U.S. Senator and former West Virginia governor Joe Manchin, earned her undergraduate degree from West Virginia University. and WVU's provost announced his resignation from that administrative post (while remaining on the faculty). On June 6, 2008, WVU President Michael Garrison resigned in the wake of the scandal.
The university initially stated that it had awarded the degree after correcting a "records error." Bresch claimed in April 2008 that she had arranged with the WVU Business School to have her "work experience" substitute for the outstanding coursework - a claim reportedly denied by the then-head of the MBA program and rejected by the panel. as criticizing the university administration for having made "a 'seriously flawed' decision fraught with favoritism" in awarding Bresch the degree; Michael Garrison, WVU President at the time, was reported to be "a family friend and former business associate of Bresch"
According to the New York Times, Bresch said in a statement that she "continues to believe she did what was required to earn her degree." After WVU announced in February 2009 that it would not rescind other degrees where students' records contained irregularities, Bresch wrote to the university demanding an explanation for what differentiated her situation from the others. The panel investigating the situation had found that "the argument that other WVU students were similarly situated to Ms. Bresch...is not the case" and that some other students' records contained only "a handful of relatively minor administrative problems".
Source @ Wikipedia
Heather Bresch active positions
Companies | Position | Start |
---|---|---|
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Chief Executive Officer | - |
Viatris Healthcare (Pty) Ltd.
Viatris Healthcare (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa. | Chief Executive Officer | - |
Former positions of Heather Bresch
Companies | Position | End |
---|---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | 2007-10-01 |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Chairman | - |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Chief Executive Officer | - |
MYLAN LABORATORIES LTD | Corporate Officer/Principal | - |
Mylan Institutional, Inc.
Mylan Institutional, Inc. Pharmaceuticals: MajorHealth Technology Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL. | Corporate Officer/Principal | - |
Training of Heather Bresch
West Virginia University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 9 |
---|---|
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan Technologies, Inc.
Mylan Technologies, Inc. Containers/PackagingProcess Industries Mylan Technologies, Inc. designs, develops, and manufactures transdermal drug delivery systems, and associated materials and technologies. The company is headquartered in St. Albans, VT. | Process Industries |
Mylan NV
Mylan NV Pharmaceuticals: MajorHealth Technology Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom. | Health Technology |
Mylan Laboratories Ltd.
Mylan Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India. | Health Technology |
Mylan Institutional, Inc.
Mylan Institutional, Inc. Pharmaceuticals: MajorHealth Technology Mylan Institutional, Inc. provides unit dose generic pharmaceuticals to hospitals and other institutions. The firm offers health care equipment and medical line of burn care products. The company was founded in 1980 and is headquartered in Rockford, IL. | Health Technology |
Mylan Pharmaceuticals, Inc.
Mylan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mylan Pharmaceuticals, Inc. develops and manufactures generic prescription products. Its product includes tablets, Fosamax, Sectral, Xanax, capsules, liquids, and transdermal patches. The company was founded in 1961 and is headquartered in Morgantown, WV. | Health Technology |
Association for Accessible Medicines
Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012. | Commercial Services |
Viatris Healthcare (Pty) Ltd.
Viatris Healthcare (Pty) Ltd. Pharmaceuticals: MajorHealth Technology Viatris Healthcare (Pty) Ltd. manufactures pharmaceuticals. its products include prescription generic, branded generic, brand-name drugs and over-the-counter remedies. The company was founded in 1961 and is headquartered in Johannesburg, South Africa. | Health Technology |
- Stock Market
- Insiders
- Heather Bresch